Sarepta Partners with StrideBio

November 26, 2019

Sarepta Partners with StrideBio

Sarepta has given StrideBio, a company with expertise in adeno-associated viruses and capsids, a license to research, develop and manufacture up to eight gene therapies. "With our partnership with StrideBio, Sarepta continues to build on its leadership position in gene therapies to treat rare diseases," said Doug Ingram, CEO. Yourway provides services for cell and gene therapy companies, and has the regulatory expertise needed to support these therapies globally.

Back to Index

Stay Connected

Want to stay informed about the latest news, updates, and opportunities at Yourway?

Join our newsletter mailing list to never miss an update!

Media

Upcoming Events

SCOPE Supply Chain & Logistics Leadership Summit

February 2-5, 2026
Orlando, Florida

Schedule a Meeting

Global Clinical Supplies Group Asia Pacific Conference

March 11-13, 2026
Conrad Seoul Hotel, South Korea

Schedule a Meeting

Media

Articles

When Quality Never Stops: How We Protect Every Shipment, Every Time

Open chat

Hello! How can I help you?